Tianjin Zhongxin Pharmaceutical Group Corp Ltd
医疗健康 · 专科与仿制药
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China. It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmological, tumor, chronic, and other diseases, as well as tonic drugs. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. The company was founded in 1915 and is based in Tianjin, the People's Republic of China.
MARKET 市值 28.53B CNY PE 13.1x
Fwd 32.1x 52W ¥33 – ¥50.97
EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 0.75 营收 YoY 4.1%
▲ ROE 27.5% 营业利润率 33.0% 净利润率 43.8%
ANALYST 股息率 12.65%